Completed
3U CubeSat with the objective to study the effect of microgravity and low fluid shear with four different experiments on biological material
In comparison with its predecessor, DIDO-2, the platform has been upgraded to include an enlarged structure, now in the so-called 3U-XL CubeSat form factor, and deployable solar panels to be able to deliver more power to the payload, required to have the necessary temperature regulation for the experiments to survive the harsh environment in space.
The payload is a miniaturized medical laboratory provided by the customer, SpacePharma, which provides end-to-end microgravity services enabling research in the field of medical drugs development in Space
Customer: Spacepharma
Start date: 2018
Launch date: September 2020